🌍July 24, 2026·8h agodiscovery

Price to sales forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

Publisher

TradingView

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: TradingView
Region: Global
Scope: discovery
Published: July 24, 2026
Language: EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on news.google.com

Leave the platform to read the original full article on the publisher site.

Source: TradingView

Scope: discovery

Open original article

Related coverage

More related coverage

매일경제/2h ago

Price to sales forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

More related coverage

Dong-A Socio to absorb pharmaceutical unit

BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026

BB Biotech AG publishes its interim report and revises its dividend policy

BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning